|
rdfs:label
|
"Dabrafenib"@de
"Dabrafenib"@el
"Dabrafenib"@nb
"Dabrafenib"@sh
"Dabrafenib"@sr
"dabrafenib"@en
"dabrafenib"@ca
"dabrafenib"@cs
"dabrafenib"@fr
"dabrafenib"@nn
"dabrafenib"@sl
"dabrafenib"@ro
"dabrafenibe"@pt
"дабрафениб"@ru
"دابرافينيب"@ar
"ダブラフェニブ"@ja
"达拉非尼"@zh
"达拉非尼"@zh-cn
"达拉非尼"@zh-hans
"達拉非尼"@zh-hant
|
|
skos:altLabel
|
"DRB436"@en
"Dabrafenib"@en
"GSK2118436"@en
"GSK2118436A"@en
"Tafinlar"@cs
"Tafinlar®"@en
"达拉菲尼"@zh
|
|
schema:description
|
"Kompozé chimik"@gcr
"cheemesch Verbindung"@lb
"chemical compound"@en
"chemical compound"@en-ca
"chemical compound"@en-gb
"chemická sloučenina"@cs
"chemická zlúčenina"@sk
"chemiese verbinding"@af
"chemische Verbindung"@de
"chemische Verbindung"@de-ch
"chemische verbinding"@nl
"component quimic"@oc
"composito chimic"@ia
"compositum chemicum"@la
"compost químic"@ca
"composto chimico"@it
"composto químico"@gl
"composto químico"@pt
"composto químico"@pt-br
"composé chimique"@fr
"compuesto quimico"@an
"compuesto químico"@es
"compuestu químicu"@ast
"compus chimic"@ro
"conposto chìmego"@vec
"cumpostu chìmicu"@scn
"cyfansoddyn cemegol"@cy
"gemyske ferbining"@fy
"kediad kimiek"@br
"keemiline ühend"@et
"kemia kombinaĵo"@eo
"kemiala kompozajo"@io
"kemiallinen yhdiste"@fi
"kemisk forbindelse"@da
"kimyasal bileşik"@tr
"kjemisk forbindelse"@nb
"kjemisk sambinding"@nn
"komponim kimik"@sq
"konposatu kimiko"@eu
"senyawa kimia"@id
"związek chemiczny"@pl
"ķīmisks savienojums"@lv
"χημική ένωση"@el
"хемиско соединение"@mk
"химическое соединение"@ru
"химично съединение"@bg
"хімічна сполука"@uk
"хімічнае злучэнне"@be
"хімічнае злучэньне"@be-tarask
"քիմիական միացություն"@hy
"תרכובת"@he
"مركب كيميائي"@ar
"کیٖمیٲیی مُرَکَب"@ks
"রাসায়নিক যৌগ"@bn
"രാസസംയുക്തം"@ml
"化合物"@yue
"化合物"@zh
"化合物"@zh-cn
"化合物"@zh-hans
"化合物"@zh-hant
"化合物"@zh-hk
"化合物"@zh-sg
"化合物"@zh-tw
"化合物"@zh-mo
|
|
schema:dateModified
|
"2026-11-04T10:17:38+00:00"^^xsd:dateTime
|
|
schema:version
|
2564648395
|
|
wikibase:identifiers
|
40
|
|
wikibase:sitelinks
|
11
|
|
wikibase:statements
|
68
|
|
p:P10245
|
wd:statement/Q3011604-477cfd06-4f8f-c40c-0ae6-8af63bf19f31
|
|
p:P10283
|
wd:statement/Q3011604-22980634-78AA-4AF9-BA6A-E18C390E3A5C
|
|
p:P11089
|
wd:statement/Q3011604-B443CEBE-29BF-4AD6-AE51-29E1BDFD32E4
|
|
p:P11143
|
wd:statement/Q3011604-7D3B8009-1EFA-4128-B8F1-17786ADFCD4B
|
|
p:P11198
|
wd:statement/Q3011604-BF15406B-4AF5-4433-9D8E-29EE381E448A
|
|
p:P11199
|
wd:statement/Q3011604-B9D5B36C-B035-41BE-9230-B4FBD3B41D0D
|
|
p:P117
|
wd:statement/Q3011604-79DDDC58-CC31-45E7-89D6-CEA577D001AB
|
|
wd:statement/Q3011604-ef0d678f-439d-c98b-7550-95ad89048c3b
|
|
p:P129
|
wd:statement/Q3011604-B848C122-7906-42F3-AC90-407E9A5C5AE3
|
|
p:P1579
|
wd:statement/Q3011604-6933A18B-514F-4EBC-8474-35F2EB5A1489
|
|
p:P2057
|
wd:statement/Q3011604-09E6C78D-537A-495D-B0A0-46A82F46DE10
|
|
p:P2067
|
wd:statement/Q3011604-3A241F47-C9F1-4408-9B14-B641B65E149A
|
|
p:P2115
|
wd:statement/Q3011604-52F650BE-C5D6-4054-9E36-90485D9D7977
|
|
p:P2175
|
wd:statement/Q3011604-4EA369A0-A9C9-4650-8766-90402AC29F12
|
|
wd:statement/Q3011604-7DF7ADA4-3F94-44E0-AB56-A9956F27CA1A
|
|
wd:statement/Q3011604-C7B2C64F-C73C-45CD-B25C-03407AE3071C
|
|
wd:statement/Q3011604-F0E3BD6B-8F96-4F6A-81D9-649741095A4F
|
|
p:P2275
|
wd:statement/Q3011604-70209072-FC9D-4029-855E-55A549BFEBE6
|
|
p:P231
|
wd:statement/Q3011604-194F01D4-FE8D-4766-9246-557A421B2415
|
|
p:P232
|
wd:statement/Q3011604-2236BA87-16E8-4AC0-A0E0-A11411635DD0
|
|
p:P233
|
wd:statement/Q3011604-FC2AF88F-2E1A-44E8-97A4-3B5B0E3AA789
|
|
p:P234
|
wd:statement/Q3011604-408FD50D-4767-42B6-94E5-A12DF5A73311
|
|
p:P235
|
wd:statement/Q3011604-0DC10CFD-141D-43CB-A91C-EF3491419200
|
|
p:P2566
|
wd:statement/Q3011604-13572468-2468-1357-eca9-bdf024681357
|
|
p:P267
|
wd:statement/Q3011604-2A3FEB98-E691-481B-BF51-9A1FE1E820D4
|
|
p:P274
|
wd:statement/Q3011604-13BD3E7B-97E7-42CA-921C-E3B76D50D87A
|
|
p:P279
|
wd:statement/Q3011604-8B0D272A-B924-42EC-8507-535C59AB9D1C
|
|
p:P2868
|
wd:statement/Q3011604-AAACD068-5706-41B8-8490-4D62F796AC74
|
|
wd:statement/Q3011604-FED511FD-6222-4888-9266-0A0D8EAB11B7
|
|
p:P2877
|
wd:statement/Q3011604-7827A7DB-A594-42DC-A69C-CD394B8C6896
|
|
p:P2892
|
wd:statement/Q3011604-1B430760-4DB9-4E7F-89E5-78377EFB8A88
|
|
wd:statement/Q3011604-FABC5F5F-3CFF-4EA9-AB2D-00D7AEEC5380
|
|
p:P31
|
wd:statement/Q3011604-7A14B11A-CAD0-4B33-AB43-07DD4A256133
|
|
p:P3117
|
wd:statement/Q3011604-D52E209D-BA3B-4777-A26A-9544F5B7378B
|
|
p:P3345
|
wd:statement/Q3011604-EDDC2230-1B92-4F83-BE3C-EB6BC494EFD7
|
|
p:P3350
|
wd:statement/Q3011604-1f0399b3-4d85-82c1-41c3-de2de75d9796
|
|
p:P3471
|
wd:statement/Q3011604-26826EB8-90CF-4362-AB47-CD3EE9FB1ED9
|
|
p:P3489
|
wd:statement/Q3011604-132E5866-2278-4AB1-82F4-49B8C3ED2E77
|
|
p:P3636
|
wd:statement/Q3011604-1A9B0F2B-E329-4869-A756-1C8C52BBDDCF
|
|
p:P366
|
wd:statement/Q3011604-BA4BF39C-985D-4E05-A6F7-D4074504D1EA
|
|
p:P373
|
wd:statement/Q3011604-8455d015-4a70-2d81-05ad-dcb951a2c629
|
|
p:P3780
|
wd:statement/Q3011604-8EB554CF-4F26-4C04-BED7-7DD53B8A647F
|
|
p:P4235
|
wd:statement/Q3011604-601216F8-2F68-4870-8D16-EAB77B5B2BDB
|
|
p:P486
|
wd:statement/Q3011604-A476FECA-C4EC-425E-BB78-17D573D684BE
|
|
p:P592
|
wd:statement/Q3011604-21A00A52-AFF6-4FAF-998B-670637503B4B
|
|
p:P595
|
wd:statement/Q3011604-FB35FEBA-AEDD-42B7-8F97-9DA7AD3232ED
|
|
p:P6366
|
wd:statement/Q3011604-54CAAF88-1E44-4816-BA4B-1033FF515684
|
|
p:P638
|
wd:statement/Q3011604-498B5DA0-0A49-44D8-874D-E3DFD8327220
|
|
wd:statement/Q3011604-B6D309A6-D091-407F-92C0-6AD280B0623C
|
|
wd:statement/Q3011604-E4D3579C-6D0C-4663-B7A8-A6246515DD18
|
|
p:P646
|
wd:statement/Q3011604-25B653BC-CF5C-4117-86E2-3818588E4C15
|
|
p:P652
|
wd:statement/Q3011604-3C3E9E2A-667E-4F4F-A17E-3DAB9C4A99A4
|
|
p:P661
|
wd:statement/Q3011604-EA8DBB40-6ED0-4A47-96E3-D6A076C785DD
|
|
p:P662
|
wd:statement/Q3011604-19B1B979-6153-4042-82FF-66EAB770D126
|
|
p:P665
|
wd:statement/Q3011604-725008A6-2056-47CF-B0ED-1865AC559BD7
|
|
p:P683
|
wd:statement/Q3011604-C25DE2C1-4C03-4895-885B-9F080C0AE430
|
|
p:P715
|
wd:statement/Q3011604-FEB51D23-947D-4A95-91BE-D31E01280E40
|
|
p:P769
|
wd:statement/Q3011604-23A7CBD0-7EC6-4EF9-89C4-1F073A44920A
|
|
wd:statement/Q3011604-2BDA2652-21E1-4098-B133-6EF02D080A92
|
|
wd:statement/Q3011604-32A60D7E-0497-4924-A185-39395A716853
|
|
wd:statement/Q3011604-69A59279-B449-4EE2-8F16-1D37AA6E8263
|
|
wd:statement/Q3011604-B496C2BD-BA39-4CE1-B5F5-34521B0A3D61
|
|
wd:statement/Q3011604-E0E41BF0-4D49-4CD6-9842-0D28DC787D33
|
|
wd:statement/Q3011604-EF0CAC57-0BE5-4238-9187-E8C3BA1712D2
|
|
wd:statement/Q3011604-FF778244-FCAE-4748-9E9C-97810B17EFA5
|
|
p:P7830
|
wd:statement/Q3011604-7B523132-7848-4C29-8AD6-AB831F18AAD1
|
|
p:P8026
|
wd:statement/Q3011604-A715B92D-7CBD-4EEA-94BF-B2B9B4477F35
|
|
p:P8494
|
wd:statement/Q3011604-81F88C43-10FB-41C7-9D2F-3F78CF543EED
|
|
p:direct-normalized/P2115
|
<http://purl.bioontology.org/ontology/NDFRT/N0000187069>
|
|
p:direct-normalized/P486
|
<http://id.nlm.nih.gov/mesh/C561627>
|
|
p:direct-normalized/P592
|
<http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL2028663>
|
|
p:direct-normalized/P6366
|
<https://makg.org/entity/2778830669>
|
|
p:direct-normalized/P638
|
<https://rdf.wwpdb.org/pdb/4XV2>
|
|
<https://rdf.wwpdb.org/pdb/5CSW>
|
|
<https://rdf.wwpdb.org/pdb/5HIE>
|
|
p:direct-normalized/P661
|
<http://rdf.chemspider.com/25948204>
|
|
p:direct-normalized/P662
|
<http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44462760>
|
|
p:direct-normalized/P665
|
<http://www.kegg.jp/entry/D10064>
|
|
p:direct-normalized/P683
|
<http://purl.obolibrary.org/obo/CHEBI_75045>
|
|
wdt:P10245
|
"a613038"
|
|
wdt:P10283
|
"C2778830669"
|
|
wdt:P11089
|
"23468438"
|
|
wdt:P11143
|
"Dabrafenib"
|
|
wdt:P11198
|
"4801"
|
|
wdt:P11199
|
"PD003542"
|
|
wdt:P117
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Dabrafenib.svg>
|
|
<http://commons.wikimedia.org/wiki/Special:FilePath/Struktur%20Dabrafenib.svg>
|
|
wdt:P129
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
wdt:P1579
|
"19689971"
|
|
wdt:P2057
|
"HMDB0250818"
|
|
wdt:P2067
|
519.101^^xsd:decimal
|
|
wdt:P2115
|
"N0000187069"
|
|
wdt:P2175
|
melanoma
|
|
metastatic melanoma
|
|
skin cancer
|
|
non-small-cell lung carcinoma
|
|
wdt:P2275
|
"dabrafenib"@en
|
|
wdt:P231
|
"1195765-45-7"
|
|
wdt:P232
|
"689-166-9"
|
|
wdt:P233
|
"CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F"
|
|
wdt:P234
|
"InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)"
|
|
wdt:P235
|
"BFSMGDJOXZAERB-UHFFFAOYSA-N"
|
|
wdt:P2566
|
"100.215.965"
|
|
wdt:P267
|
"L01XE23"
|
|
wdt:P274
|
"C₂₃H₂₀F₃N₅O₂S₂"
|
|
wdt:P279
|
chemical compound
|
|
wdt:P2868
|
antineoplastic
|
|
protein kinase inhibitors
|
|
wdt:P2877
|
"806377"
|
|
wdt:P2892
|
"C2826139"
|
|
"C3467876"
|
|
wdt:P31
|
type of chemical entity
|
|
wdt:P3117
|
"DTXSID20152499"
|
|
wdt:P3345
|
"1424911"
|
|
wdt:P3350
|
"9458"
|
|
wdt:P3471
|
"50894"
|
|
wdt:P3489
|
US pregnancy category D
|
|
wdt:P3636
|
"P06"
|
|
wdt:P366
|
medication
|
|
wdt:P373
|
"Dabrafenib"
|
|
wdt:P3780
|
Tafinlar
|
|
wdt:P4235
|
"dabrafenib"
|
|
wdt:P486
|
"C561627"
|
|
wdt:P592
|
"CHEMBL2028663"
|
|
wdt:P595
|
"6494"
|
|
wdt:P6366
|
"2778830669"
|
|
wdt:P638
|
"4XV2"
|
|
"5CSW"
|
|
"5HIE"
|
|
wdt:P646
|
"/m/0pcvk7y"
|
|
wdt:P652
|
"QGP4HA4G1B"
|
|
wdt:P661
|
"25948204"
|
|
wdt:P662
|
"44462760"
|
|
wdt:P665
|
"D10064"
|
|
wdt:P683
|
"75045"
|
|
wdt:P715
|
"DB08912"
|
|
wdt:P769
|
clarithromycin
|
|
ketoconazole
|
|
voriconazole
|
|
ritonavir
|
|
crizotinib
|
|
fosphenytoin
|
|
idelalisib
|
|
wdt:P7830
|
"Dabrafenib"
|
|
wdt:P8026
|
LiverTox toxicity likelihood category E*
|
|
wdt:P8494
|
"DTXCID8074990"
|